Xiaomao Xu
About
In The Last Decade
Xiaomao Xu
34 papers receiving 400 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 114
- Infectious Diseases 112
- Pulmonary and Respiratory Medicine 107
- Cancer Research 70
- Epidemiology 49
Countries citing papers authored by Xiaomao Xu
This map shows the geographic impact of Xiaomao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomao Xu more than expected).
Fields of papers citing papers by Xiaomao Xu
This network shows the impact of papers produced by Xiaomao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomao Xu. The network helps show where Xiaomao Xu may publish in the future.
Co-authorship network of co-authors of Xiaomao Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomao Xu. A scholar is included among the top collaborators of Xiaomao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomao Xu. Xiaomao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 14 | |
| 8 | 0 | |
| 9 | 14 | |
| 10 | 4 | |
| 11 | 30 | |
| 12 | 6 | |
| 13 | 13 | |
| 14 | 59 | |
| 15 | 6 | |
| 16 | 2 | |
| 17 | [Correlation of three common variation loci in von Willebrand factor gene and pulmonary thromboembolism disease]. | 1 |
| 18 | 44 | |
| 19 | Outcome and prognosis for patients younger than thirty with primary lung cancer. | 6 |
| 20 | [The effect of montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction]. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.